KPTI
Karyopharm Therapeutics Inc.NASDAQHealthcare$5.89+7.30%ClosedMarket Cap: $50.3M
As of 2026-04-06
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-30 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-25 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-25 | Baird | maintain | Outperform | Outperform |
| 2026-02-18 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-04 | RBC Capital | maintain | Outperform | Outperform |
| 2025-10-13 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2025-10-09 | Baird | maintain | Outperform | Outperform |
| 2025-10-09 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-08-12 | Baird | maintain | Outperform | Outperform |
| 2025-07-16 | HC Wainwright & Co. | downgrade | Neutral | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.20 | $168.2M | 3 |
| Sun Dec 31 | $-1.21 | $216.1M | 3 |
| Mon Dec 31 | $3.58 | $352.3M | 1 |
| Tue Dec 31 | $6.98 | $505.4M | 1 |